Pharma and Biotech Daily: Eli Lilly's Lawsuit, Novo Nordisk's Marketing, and Industry Hiring Trends

Pharma and BioTech Daily

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Eli Lilly has requested to join a lawsuit against the FDA filed by compounding pharmacies, indicating the outcome could impact its business. Despite having inferior GLP-1 products, Novo Nordisk is outperforming Lilly due to superior marketing strategies. The pharmaceutical industry is seeing an increase in hiring for computational biology and data science roles. Regeneron's acquisition of Oxular has resulted in the elimination of the Oxular workforce.In other news, Roche has committed potential funding for an ADC from China, Neumora's depression drug failed in pivotal trials, and Sangamo's stock dropped as Pfizer ended a gene therapy pact. Job opportunities include positions in marketing, experimental medicine, external engagement, and congress meeting planning.